Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Open accessThe DOI matches its Crossref record; 82 of the 84 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic options. To better understand the inflammatory responses that precede and concur with collagen deposition, we used three models of pulmonary fibrosis and identify a critical mechanistic role for IL-17A. After exposure to bleomycin (BLM), but not Schistosoma mansoni eggs, IL-17A produced by CD4+ and γδ+ T cells induced significant neutrophilia and pulmonary fibrosis. Studies conducted with C57BL/6 il17a−/− mice confirmed an essential role for IL-17A. Mechanistically, using ifnγ−/−, il10−/−, il10−/−il12p40−/−, and il10−/−il17a−/− mice and TGF-β blockade, we demonstrate that IL-17A–driven fibrosis is suppressed by IL-10 and facilitated by IFN-γ and IL-12/23p40. BLM-induced IL-17A production was also TGF-β dependent, and recombinant IL-17A–mediated fibrosis required TGF-β, suggesting cooperative roles for IL-17A and TGF-β in the development of fibrosis. Finally, we show that fibrosis induced by IL-1β, which mimics BLM-induced fibrosis, is also highly dependent on IL-17A. IL-17A and IL-1β were also increased in the bronchoalveolar lavage fluid of patients with IPF. Together, these studies identify a critical role for IL-17A in fibrosis, illustrating the potential utility of targeting IL-17A in the treatment of drug and inflammation-induced fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17A increases and stabilizes TGF-βRII expression on fibroblasts, thereby enhancing their sensitivity to TGF-β120”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [120]
In the citing paper
“the functions of IL-17 include stimulation of ECM production, collagen disposition, and mediation of TGF-β signaling (144).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [144]
In the citing paper
“murine studies in which administration of IL-17A is sufficient to induce collagen accumulation and fibrotic lesions (144, 145)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 6×
“More recently, studies have also suggested important inflammatory activities for TGF, with TGF providing an integral differentiation signal for the develop ment of proinflammatory IL17A–secreting cells (Bettelli et al., 2006; Veldhoen et al., 2006).”
BackgroundResultInfluentialCellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Self-citationIL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 5×
“These observations also suggest that IL10 inhibits the development of BLMinduced fibrosis by targeting the proinflammatory IL23–IL17A pathway rather than the IL12–IFN axis.”
BackgroundInfluentialVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 3×
“However, recent studies demonstrated that TGF is also critically involved in the development of IL17A–producing lymphocytes (Bettelli et al., 2006; Veldhoen et al., 2006), which regulate the development of a variety of inflammatory and autoimmune diseases (Tesmer et al., 2008).”
BackgroundSutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553 · cited 3×
“Similarly, IL1 can stimulate IL17A production (Sutton et al., 2009), and IL1 is a critical mediator of pulmonary fibrosis (Gasse et al., 2007).”
BackgroundMcGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520 · cited 3×
“Similar to previ ous studies (McGeachy et al., 2007; Stumhofer et al., 2007), IL10 was often coexpressed with IL17A and RoRt, sug gesting that Th17 cells may develop into IL10–secreting cells to limit Th17 effector function.”
ResultInduction and effector functions of TH17 cells
Bettelli, E., Korn, T., Oukka, M., & Kuchroo, V. K. (2008) · Nature · doi:10.1038/nature07036 · Cited by 1,216 · cited 2×
“, 2006), which regulate the pathogenesis of a variety of autoimmune and inflammatory diseases (Bettelli et al., 2008).”
BackgroundTesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., & Iwakura, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00391-6 · Cited by 1,052 · cited 1×
“However, IL17A has been implicated in IL13– associated airway hyperreactivity (Nakae et al., 2002).”
BackgroundOrtiz, L. A., DuTreil, M., Fattman, C., Pandey, A. C., Torres, G., Go, K., & Phinney, D. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704421104 · Cited by 1,019 · cited 1×
“These observations are consistent with studies that suggested IL10 could regulate the magnitude and effec tor function of Th17 responses (Fitzgerald et al., 2007; McGeachy et al., 2007; Chang et al., 2008).”
Result
Cited by
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
“IL-1β stimulates T H 17 cells to produce IL-17, which was identified as an important inducer of bleomycin-induced pulmonary fibrosis, a fibrotic disorder with characteristics that are similar to those of IP”
BackgroundSelf-citationMechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Self-citationFibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Self-citationTargeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Macrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
Self-citationInflammation and metabolism in tissue repair and regeneration
Eming, S. A., Wynn, T. A., & Martin, P. (2017) · Science · doi:10.1126/science.aam7928 · Cited by 1,369
Self-citationIntegrating mechanisms of pulmonary fibrosis
Wynn, T. A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110551 · Cited by 1,274
“IL-17A is increased in the bronchoalveolar lavage (BAL) fluid of patients with IPF (Wilson et al., 2010).”
BackgroundInfluentialSelf-citationFunctional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055
Self-citationGalli, S. J., Borregaard, N., & Wynn, T. A. (2011) · Nature Immunology · doi:10.1038/ni.2109 · Cited by 1,055
Self-citationMeng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711
The Impact of TGF-β on Lung Fibrosis: From Targeting to Biomarkers
Fernandez, I. E., & Eickelberg, O. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201203-023aw · Cited by 679
Therapy for Fibrotic Diseases: Nearing the Starting Line
Friedman, S. L., Sheppard, D., Duffield, J. S., & Violette, S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004700 · Cited by 655
“IL-13, IL-17, and related cytokines are interesting potential targets for treatment for chronic fibrotic diseases.”
BackgroundInfluentialHost Responses in Tissue Repair and Fibrosis
Duffield, J. S., Lupher, M., Thannickal, V. J., & Wynn, T. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163930 · Cited by 624
Self-citationWollin, L., Maillet, I., Quesniaux, V., Holweg, A., & Ryffel, B. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208223 · Cited by 633
“IL-1b was shown to have an important role in driving the development of fibrosis (Wilson et al., 2010).”
BackgroundEvolving therapies for liver fibrosis
Schuppan, D., & Kim, Y. O. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66028 · Cited by 595
Crosstalk between fibroblasts and inflammatory cells
Van Linthout, S., Miteva, K., & Tschope, C. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu062 · Cited by 569
Tuberculosis and lung damage: from epidemiology to pathophysiology
Ravimohan, S., Kornfeld, H., Weissman, D., & Bisson, G. P. (2018) · European Respiratory Review · doi:10.1183/16000617.0077-2017 · Cited by 531
“Additionally, IL-1β has been linked to fibrosis in patients with idiopathic pulmonary fibrosis (IPF), which is a progressive and fatal lung disease characterised by restrictive ventilatory defects [115].”
BackgroundMack, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.11.010 · Cited by 514
Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer
Buechler, M. B., Fu, W., & Turley, S. J. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.021 · Cited by 494
The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin
Weaver, C. T., Elson, C. O., Fouser, L. A., & Kolls, J. K. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130318 · Cited by 462
The Formation and Function of Granulomas
Pagán, A. J., & Ramakrishnan, L. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100022 · Cited by 430
Molecular and cellular mechanisms of pulmonary fibrosis
Todd, N. W., Luzina, I. G., & Atamas, S. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-11 · Cited by 418
“[25,89,90]”
Neutrophil extracellular traps promote differentiation and function of fibroblasts
Chrysanthopoulou, A., Mitroulis, I., Apostolidou, E., Arelaki, S., Mikroulis, D., Konstantinidis, T., Sivridis, E., Koffa, M., Giatromanolaki, A., Boumpas, D. T., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4359 · Cited by 404
Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A
Sonnenberg, G. F., Nair, M. G., Kirn, T. J., Zaph, C., Fouser, L. A., & Artis, D. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092054 · Cited by 380
“Additionally, a recent report identified that in a model of bleomycin-induced fibrosis, IL-17A can act cooperatively with TGF- to promote disease (Wilson et al., 2010).”
BackgroundThe interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Moretti, L., Stalfort, J., Barker, T. H., & Abebayehu, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101530 · Cited by 393
“s a pyrogen (292) Fibrosis (293) ion, macrophage Tissue regeneration, asthma, T-cell immunity (295–297) s a pyrogen (17) Broad involvement with inflammatory pathologies (17) Histological inflammation (298) 6) Scarless fetal healing (299) T-cell immunity (300) Tissue regeneration, asthma, T-cell immunity (295–297, 302)…”
BackgroundRegulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection
Nandi, B., & Behar, S. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110919 · Cited by 374
“Similar findings were reported in the mouse model of idiopathic pulmonary fibrosis where IL-17 and TGF- were associated with fibrosis (Wilson et al., 2010).”
ResultIL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis
Hams, E., Armstrong, M. E., Barlow, J. L., Saunders, S. P., Schwartz, C., Cooke, G., Fahy, R. J., Crotty, T. B., Hirani, N., Flynn, R. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315854111 · Cited by 376
Cytokine mediated tissue fibrosis
Borthwick, L. A., Wynn, T. A., & Fisher, A. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.014 · Cited by 375
Self-citationCelada, L. J., Kropski, J. A., Herazo-Maya, J. D., Luo, W., Creecy, A., Abad, A. T., Chioma, O. S., Lee, G., Hassell, N. E., Shaginurova, G. I., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar8356 · Cited by 363
“Increased IL17A in the bronchoalveolar lavage of idiopathic pulmonary fibro sis (IPF) patients has also been reported (9).”
Macrophage and Fibroblast Interactions in Biomaterial‐Mediated Fibrosis
Witherel, C. E., Abebayehu, D., Barker, T. H., & Spiller, K. L. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801451 · Cited by 374
Mi, S., Li, Z., Yang, H.-Z., Liu, H., Wang, J.-P., Ma, Y.-G., Wang, X.-X., Liu, H.-Z., Sun, W., & Hu, Z.-W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004081 · Cited by 370
“(13) in that TGF-b1 is required for IL17A–mediated pulmonary fibrosis.”
BackgroundInfluentialThe Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
O’Dwyer, D. N., Dickson, R. P., & Moore, B. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600279 · Cited by 362
“Several studies have implicated IL-17 in hepatic fibrosis, and certain experimental models of pulmonary fibrosis are IL-17A–dependent (120, 122, 123).”
BackgroundImmune mechanisms in pulmonary fibrosis
Kolahian, S., Fernandez, I. E., Eickelberg, O., & Hartl, D. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0121tr · Cited by 349
Wick, G., Grundtman, C., Mayerl, C., Wimpissinger, T.-F., Feichtinger, J., Zelger, B., Sgonc, R., & Wolfram, D. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095937 · Cited by 327
“Wilson and coworkers (23) have shown that bleomycin-induced pulmonary fibrosis is IL-17A dependent and requires TGF-β1, whereas Braun et al.”
Tan, Z., Qian, X., Jiang, R., Liu, Q., Wang, Y., Chen, C., Wang, X., Ryffel, B., & Sun, B. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203013 · Cited by 330
“IL-17A is involved in neutrophil recruitment and angiogenesis (34), and IL-17A expression is partially dependent on IL-1 and IL-23 signaling (8, 35).”
BackgroundBaldeviano, G. C., Barin, J. G., Talor, M. V., Srinivasan, S., Bedja, D., Zheng, D., Gabrielson, K., Iwakura, Y., Rose, N. R., & Cihakova, D. (2010) · Circulation Research · doi:10.1161/circresaha.109.213157 · Cited by 334
Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?
Byrne, A. J., Maher, T. M., & Lloyd, C. M. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.02.004 · Cited by 315
“Using IL-17-deficient mice, Wilson et al. demonstrated that both bleomycin and IL-1b-induced pulmonary fibrosis are dependent on IL-17A [88].”
Minagawa, S., Araya, J., Numata, T., Nojiri, S., Hara, H., Yumino, Y., Kawaishi, M., Odaka, M., Morikawa, T., Nishimura, S. L., et al. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00097.2010 · Cited by 323
Li, R., Wang, X., Ji, Z., Sun, B., Zhang, H., Chang, C. H., Lin, S., Meng, H., Liao, Y.-P., Wang, M., et al. (2013) · ACS Nano · doi:10.1021/nn305567s · Cited by 317
“represents amajor cytokine used by pulmonarymacrophages to initiate a cascade of events in cooperation with epithelial cells that culminate in pulmonary fibrosis.(38)”
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
“As shown in Figure 3, the functions of IL-17 include stimulation of ECM production, collagen disposition, and mediation of TGF-β signaling (144).”
BackgroundImmune dysregulation as a driver of idiopathic pulmonary fibrosis
Shenderov, K., Collins, S. L., Powell, J. D., & Horton, M. R. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143226 · Cited by 295
“Several of these reports suggested this was due to skewing of lung CD4+ T cells away from Th1 patients (91).”
BackgroundBarron, L., & Wynn, T. A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00414.2010 · Cited by 304
Self-citationSarcoidosis is a Th1/Th17 multisystem disorder
Facco, M., Cabrelle, A., Teramo, A., Olivieri, V., Gnoato, M., Teolato, S., Ave, E., Gattazzo, C., Fadini, G. P., Calabrese, F., et al. (2011) · Thorax · doi:10.1136/thx.2010.140319 · Cited by 295
“seem to point out. The involvement of IL-17A in the development of fibrosis was recently demonstrated in a murine model of bleomycin-induced pulmonary fibrosis.”
BackgroundSavin, I. A., Zenkova, M. A., & Sen’kova, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314959 · Cited by 279
The IL-1 cytokine family and its role in inflammation and fibrosis in the lung
Borthwick, L. A. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0559-z · Cited by 294
The pathogenesis of idiopathic pulmonary fibrosis
Coward, W. R., Saini, G., & Jenkins, G. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810379801 · Cited by 272
“More recently the Th17 cytokine IL17A has been shown to promote fibrosis via a TGF-b1-dependent mechanism [Wilson et al. 2010].”
BackgroundFibrosis Related Inflammatory Mediators: Role of the IL‐10 Cytokine Family
Sziksz, E., Pap, D., Lippai, R., Béres, N. J., Fekete, A., Szabó, A. J., & Vannay, Á. (2015) · Mediators of Inflammation · doi:10.1155/2015/764641 · Cited by 265
“In the present review we provide an overview of the common key mediators of organ fibrosis highlighting the role of interleukin-10 (IL-10) cytokine family members (IL-10, IL-19, IL-20, IL-22, IL-24, and IL-26), which recently came into focus as tissue remodeling-related inflammatory cytokines.”
BackgroundCellular and molecular mechanisms of intestinal fibrosis
Speca, S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i28.3635 · Cited by 272
Vimentin regulates activation of the NLRP3 inflammasome
dos Santos, G., Rogel, M. R., Baker, M. A., Troken, J. R., Urich, D., Morales-Nebreda, L., Sennello, J. A., Kutuzov, M. A., Sitikov, A., Davis, J. M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7574 · Cited by 274
Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
Shi, X., Young, C. D., Zhou, H., & Wang, X.-J. (2020) · Biomolecules · doi:10.3390/biom10121666 · Cited by 243
Su, S., Zhao, Q., He, C., Huang, D., Liu, J., Chen, F., Chen, J., Liao, J.-Y., Cui, X., Zeng, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms9523 · Cited by 253
Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis
Yamashita, C. M., Dolgonos, L., Zemans, R. L., Young, S. K., Robertson, J., Briones, N., Suzuki, T., Campbell, M. N., Gauldie, J., Radisky, D. C., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.041 · Cited by 247
γδ T cells protect against lung fibrosis via IL-22
Simonian, P. L., Wehrmann, F., Roark, C. L., Born, W. K., O'Brien, R. L., & Fontenot, A. P. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100061 · Cited by 242
Yang, D., Chen, X., Wang, J., Lou, Q., Lou, Y., Li, L., Wang, H., Chen, J., Wu, M., Song, X., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.02.001 · Cited by 250
Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
Blackwell, T. S., Tager, A. M., Borok, Z., Moore, B. B., Schwartz, D. A., Anstrom, K. J., Bar-Joseph, Z., Bitterman, P., Blackburn, M. R., Bradford, W., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1141ws · Cited by 236
Self-citationRole of interleukins in the pathogenesis of pulmonary fibrosis
She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00437-9 · Cited by 219
Myofibroblast differentiation and survival in fibrotic disease
Kis, K., Liu, X., & Hagood, J. S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001967 · Cited by 224
Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis
Redente, E. F., Jacobsen, K. M., Solomon, J. J., Lara, A. R., Faubel, S., Keith, R. C., Henson, P. M., Downey, G. P., & Riches, D. W. H. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00122.2011 · Cited by 215
Ma, H.-Y., Yamamoto, G., Xu, J., Liu, X., Karin, D., Kim, J. Y., Alexandrov, L. B., Koyama, Y., Nishio, T., Benner, C., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.12.016 · Cited by 216
Kramann, R., DiRocco, D. P., & Humphreys, B. D. (2013) · The Journal of Pathology · doi:10.1002/path.4253 · Cited by 211
The Role of Microglia and Macrophages in CNS Homeostasis, Autoimmunity, and Cancer
Yin, J., Valin, K. L., Dixon, M. L., & Leavenworth, J. W. (2017) · Journal of Immunology Research · doi:10.1155/2017/5150678 · Cited by 202
IL-1 and IL-23 Mediate Early IL-17A Production in Pulmonary Inflammation Leading to Late Fibrosis
Gasse, P., Riteau, N., Vacher, R., Michel, M.-L., Fautrel, A., di Padova, F., Fick, L., Charron, S., Lagente, V., Eberl, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023185 · Cited by 208
“Our study showed for the first time that IL-23p19 and IL-17RA signaling were necessary to trigger late pulmonary inflammation and fibrosis and confirmed by IL17A neutralization that IL-17A is required for late disease [11].”
BackgroundResultInfluentialFibrosis in IBD: from pathogenesis to therapeutic targets
Rieder, F., Mukherjee, P. K., Massey, W. J., Wang, Y., & Fiocchi, C. (2024) · Gut · doi:10.1136/gutjnl-2023-329963 · Cited by 185
IL-17 in the lung: the good, the bad, and the ugly
Gurczynski, S. J., & Moore, B. B. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00344.2017 · Cited by 202
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
Khanna, D., Tashkin, D. P., Denton, C. P., Renzoni, E. A., Desai, S. R., & Varga, J. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0563ci · Cited by 195
Zhang, J., Wang, D., Wang, L., Wang, S., Roden, A. C., Zhao, H., Li, X., Prakash, Y. S., Matteson, E. L., Tschumperlin, D. J., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00301.2018 · Cited by 194
“Murine studies using the bleomycin-induced lung fibrosis model demonstrated that IL-17A participates in mediation of transforming growth factor- signaling (18, 28, 37, 65), and stimulates collagen and ECM deposition.”
BackgroundCellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis
Ueha, S., Shand, F. H. W., & Matsushima, K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00071 · Cited by 182
Kitamura, H., Cambier, S., Somanath, S., Barker, T., Minagawa, S., Markovics, J., Goodsell, A., Publicover, J., Reichardt, L., Jablons, D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45589 · Cited by 189
WNT/β-Catenin Signaling Induces IL-1β Expression by Alveolar Epithelial Cells in Pulmonary Fibrosis
Aumiller, V., Balsara, N., Wilhelm, J., Günther, A., & Königshoff, M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0524oc · Cited by 181
Cardiac fibroblasts mediate IL-17A–driven inflammatory dilated cardiomyopathy
Wu, L., Ong, S., Talor, M. V., Barin, J. G., Baldeviano, G. C., Kass, D. A., Bedja, D., Zhang, H., Sheikh, A., Margolick, J. B., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132126 · Cited by 181
“Similar profibrotic functions of IL17A have been reported in cirrhosis (Lan et al., 2009) and fibrotic lung injury (Wilson et al., 2010) models.”
BackgroundInfluentialTruchetet, M.-E., Brembilla, N. C., Montanari, E., Allanore, Y., & Chizzolini, C. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3486 · Cited by 173
“It should be noticed that IL17A has been shown to participate in an IL-1-dependent manner to the development of bleomycin-induced mouse lung fibrosis [43] and IL-17 may directly stimulate collagen synthesis in rodent fibroblasts [44,45].”
BackgroundCellular and Molecular Mediators of Intestinal Fibrosis
Lawrance, I. C., Rogler, G., Bamias, G., Breynaert, C., Florholmen, J., Pellino, G., Reif, S., Speca, S., & Latella, G. (2015) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.09.008 · Cited by 174
Foxm1 transcription factor is required for lung fibrosis and epithelial‐to‐mesenchymal transition
Balli, D., Ustiyan, V., Zhang, Y., Wang, I., Masino, A. J., Ren, X., Whitsett, J. A., Kalinichenko, V. V., & Kalin, T. V. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.336 · Cited by 177
“…(BAL) cell counts (Supplementary Figure 3B). mRNAs encoding pro-inflammatory cytokines Ccl2, Cxcl5 and IL-1 b , all known mediators of pulmonary inflammation and fibrosis (Rose et al , 2003; Wilson et al , 2010; Liu et al , 2011), were increased while Ccl3 was not changed (Supplementary Figure 3C).”
IL-1 family cytokines trigger sterile inflammatory disease
Lukens, J. R., Gross, J. M., & Kanneganti, T.-D. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00315 · Cited by 172
“…was shown to attenuate proinflammatory cytokine production, immune cell recruitment, and fibrosis in response to a variety of irritants including bleomycin, cigarette smoke, diesel fuel, silica, and asbestos (Cassel et al., 2008; Hornung et al., 2008; Wilson et al., 2010; Yazdi et al., 2010).”
BackgroundUchida, M., Shiraishi, H., Ohta, S., Arima, K., Taniguchi, K., Suzuki, S., Okamoto, M., Ahlfeld, S. K., Ohshima, K., Kato, S., et al. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0115oc · Cited by 174
Chung, L., Maestas, D. R., Lebid, A., Mageau, A., Rosson, G. D., Wu, X., Wolf, M. T., Tam, A. J., Vanderzee, I., Wang, X., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax3799 · Cited by 172
Strategies for anti-fibrotic therapies
Rosenbloom, J., Mendoza, F. A., & Jimenez, S. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.007 · Cited by 170
Caër, C., Rouault, C., Le Roy, T., Poitou, C., Aron-Wisnewsky, J., Torcivia, A., Bichet, J.-C., Clément, K., Guerre-Millo, M., & André, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-02660-w · Cited by 157
MicroRNA-326 Regulates Profibrotic Functions of Transforming Growth Factor-β in Pulmonary Fibrosis
Das, S., Kumar, M., Negi, V., Pattnaik, B., Prakash, Y. S., Agrawal, A., & Ghosh, B. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0195oc · Cited by 162
“Bleomycin-induced fibrosis is associated with a Th1/Th17 response at early time points (25); this finding supports our data, which show the presence of miR-326 during the onset of the disease.”
ResultInterleukin-36γ–producing macrophages drive IL-17–mediated fibrosis
Sommerfeld, S. D., Cherry, C., Schwab, R. M., Chung, L., Maestas, D. R., Laffont, P., Stein, J. E., Tam, A., Ganguly, S., Housseau, F., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aax4783 · Cited by 161
Madala, S. K., Schmidt, S., Davidson, C. R., Ikegami, M., Wert, S. E., & Hardie, W. D. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0237oc · Cited by 159
Self-citationIL-17 Mediates Immunopathology in the Absence of IL-10 Following Leishmania major Infection
Gonzalez-Lombana, C., Gimblet, C., Bacellar, O., Oliveira, W. W., Passos, S., Carvalho, L. P., Goldschmidt, M., Carvalho, E. M., & Scott, P. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003243 · Cited by 158
“Our results are consistent with studies indicating an important role for IL-1b in several models of IL-17mediated disease [28,41–44], and suggest that IL-1 plays a critical role in inducing IL-17 mediated pathology in leishmaniasis.”
BackgroundResultMacrophage heterogeneity in respiratory diseases
Boorsma, C. E., Draijer, C., & Melgert, B. N. (2013) · Mediators of Inflammation · doi:10.1155/2013/769214 · Cited by 126
Neutralizing IL-17 Prevents Obliterative Bronchiolitis in Murine Orthotopic Lung Transplantation
Fan, L., Benson, H. L., Vittal, R., Mickler, E. A., Presson, R., Fisher, A. J., Cummings, O. W., Heidler, K. M., Keller, M. R., Burlingham, W. J., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03482.x · Cited by 154
“Since OB is a fibrotic lesion, then data showing IL-17A blockade prevents OB are consistent with studies of nontransplant-related lung disease that showed blocking IL-17A prevented fibrosis (31).”
ResultAge-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation
Stout-Delgado, H. W., Cho, S. J., Chu, S. G., Mitzel, D. N., Villalba, J., El-Chemaly, S., Ryter, S. W., Choi, A. M. K., & Rosas, I. O. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0222oc · Cited by 144
“Alveolar macrophages, the most abundant cells in bronchoalveolar lavage (BAL) fluid, can release cytokines, growth factors, extracellular matrix proteins and metalloproteases that contribute to alveolar injury, aberrant lung repair, and pulmonary fibrosis (17, 18).”
BackgroundSelf-citationO'Donoghue, R. J. J., Knight, D. A., Richards, C. D., Prêle, C. M., Lau, H. L., Jarnicki, A. G., Jones, J., Bozinovski, S., Vlahos, R., Thiem, S., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100604 · Cited by 152
Fabre, T., Kared, H., Friedman, S. L., & Shoukry, N. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400861 · Cited by 150
“IL-17A can also enhance fibrosis indirectly by inducing expression of TGF-b1 (22, 26).”
BackgroundPotential roles of interleukin‐17A in the development of skin fibrosis in mice
Okamoto, Y., Hasegawa, M., Matsushita, T., Hamaguchi, Y., Huu, D. L., Iwakura, Y., Fujimoto, M., & Takehara, K. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34643 · Cited by 152
Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patients
Li, D., Cai, W., Gu, R., Zhang, Y., Zhang, H., Tang, K., Xu, P., Katirai, F., Shi, W., Wang, L., et al. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.10.001 · Cited by 153
Regulatory T cells in skin are uniquely poised to suppress profibrotic immune responses
Kalekar, L. A., Cohen, J. N., Prevel, N., Sandoval, P. M., Mathur, A. N., Moreau, J. M., Lowe, M. M., Nosbaum, A., Wolters, P. J., Haemel, A., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw2910 · Cited by 142
Mechanisms of lung disease development in rheumatoid arthritis
Wang, D., Zhang, J., Lau, J., Wang, S., Taneja, V., Matteson, E. L., & Vassallo, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0275-x · Cited by 155
Statins and Pulmonary Fibrosis: The Potential Role of NLRP3 Inflammasome Activation
Xu, J.-F., Washko, G. R., Nakahira, K., Hatabu, H., Patel, A. S., Fernandez, I. E., Nishino, M., Okajima, Y., Yamashiro, T., Ross, J. C., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1574oc · Cited by 141
Self-citationMacrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis
Borthwick, L. A., Barron, L., Hart, K. M., Vannella, K. M., Thompson, R. W., Oland, S., Cheever, A., Sciurba, J., Ramalingam, T. R., Fisher, A. J., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.34 · Cited by 138
“A likely beneficial effect from neutrophils in IL-13-dependent fibrosis would contrast with their presumed role as a profibrotic effector in other models, such as IL-1- and transforming growth factorb-dependent bleomycin-induced lung injury.(47) Previous studies using clodronate liposomes to deplete phagocytic cells s…”
BackgroundSelf-citationLabib, S., Williams, A., Yauk, C. L., Nikota, J. K., Wallin, H., Vogel, U. B., & Halappanavar, S. S. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0125-9 · Cited by 145
“This initial response progresses to the activation of CD4+ T cells, which contribute additional cytokines that are crucial to the development of fibrosis [63, 64].”
BackgroundThe Roles of Immune Cells in the Pathogenesis of Fibrosis
Huang, E., Peng, N., Xiao, F., Hu, D., Wang, X., & Lu, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155203 · Cited by 143
“Moreover, intratracheal administration of IL-17 was shown to induce collagen accumulation and fibrotic lesions while neutralization of IL-17 reduced tissue fibrosis, indicating a pro-fibrotic role of IL-17 in chemical-induced fibrosis [86].”
BackgroundA mechanistic review of silica-induced inhalation toxicity
Kawasaki, H. (2015) · Inhalation Toxicology · doi:10.3109/08958378.2015.1066905 · Cited by 139
“, 2012), a bleomycin-induced fibrosis model (Gasse et al., 2011; Wilson et al., 2010), and an experimental autoimmune encephalomyelitis model (Lalor et al.”
Reilkoff, R. A., Peng, H., Murray, L. A., Peng, X., Russell, T., Montgomery, R., Feghali-Bostwick, C., Shaw, A., Homer, R. J., Gulati, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201206-1109oc · Cited by 135
IL-17 in the Pathogenesis of Disease: Good Intentions Gone Awry
Majumder, S., & McGeachy, M. J. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101819-092536 · Cited by 146
“Mice deficient in IL-17 are resistant to bleomycin-induced lung fibrosis(72).”
BackgroundDoke, T., Abedini, A., Aldridge, D. L., Yang, Y.-W., Park, J., Hernandez, C. M., Balzer, M. S., Shrestra, R., Coppock, G., Rico, J. M. I., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01200-7 · Cited by 129
Metadata
- Authors
- Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115 3
- Biomedical Research Institute (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-02-22
- Volume
- 207
- Issue
- 3
- Pages
- 535-552
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2839145
- OpenAlex
- W2095715691
- Cited by
- 730
- References
- 84
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 68 · 2023: 45 · 2022: 47 · 2021: 39 · 2020: 38 · 2019: 51 · 2018: 47 · 2017: 48 · 2016: 42 · 2015: 42 · 2014: 40 · 2013: 57 · 2012: 45
- FWCI
- 41.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- idiopathic pulmonary fibrosis, IL-17A, bleomycin-induced lung injury, IL-1β, pulmonary fibrosis, TGF-beta, IL-10, interferon-gamma, IL-12/23p40, γδ T cells, CD4+ T cells, neutrophilia, Schistosoma mansoni eggs, bronchoalveolar lavage, IL-17A blockade
- MeSH terms
- Animals, Bleomycin, Interferon-gamma, Lung, Male, Mice, Inbred C57BL, Pulmonary Fibrosis, Schistosoma mansoni, Schistosomiasis mansoni, CD4-Positive T-Lymphocytes, Interleukin-10, Mice, Knockout, Interleukin-13, Interleukin-17, Mice, Interleukin-1beta, Interleukin-12 Subunit p40
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.